The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice.

While the data show a trend in the ability of imatinib to reduce IL-1β concentrations in this model, the difference between the vehicle- and imatinib-treated groups did not reach statistical significance ( P = 0.06) ( Fig 1C ).

also in 111,027 other papers